SBRASabra Health Care REIT demonstrates solid fundamental strength with a consistent dividend and a diversified portfolio. Thematic tailwinds in healthcare real estate are positive, though recent technicals suggest potential short-term price consolidation. Overall a balanced investment for income-focused investors.
The company operates within the growing healthcare real estate sector, benefiting from demographic trends and increasing demand for senior housing and healthcare facilities.
Sabra exhibits strong profitability, consistent dividend payments, and a manageable debt structure, supported by stable revenue generation from its real estate assets.
The stock has shown recent volatility, trading below its 50-day moving average. While the long-term trend remains somewhat positive, short-term indicators suggest a period of consolidation or potential further decline.
| Factor | Score |
|---|---|
| Healthcare Demographics | 85 |
| Diversification | 80 |
| Healthcare Real Estate Market Trends | 75 |
| Interest Rate Sensitivity | 55 |
| Factor | Score |
|---|---|
| Valuation | 65 |
| Profitability | 80 |
| Growth | 75 |
| Balance Sheet Health | 70 |
| Cash Flow | 95 |
| Factor | Score |
|---|---|
| Trend Analysis | 40 |
| Momentum | 45 |
| Volume Confirmation | 60 |
| Support & Resistance | 70 |
Consistent EPS Performance
Company has reported actual EPS equal to or exceeding analyst estimates in the last two reported quarters (2025 Q2 and 2025 Q1), indicating a track record of meeting or beating earnings expectations.
Attractive P/E Ratio Relative to Recent Performance
The trailing P/E ratio of 37.4 for TTM is high, but recent quarterly data shows improving net income and P/E ratios (e.g., 2025 Q1 P/E of 101.4, suggesting improvement from a higher base or anticipation of future growth).
High Trailing P/E Ratio
The trailing P/E ratio for TTM is 37.4, and for 2024, it is 31.4. While net income is positive, these multiples are high, especially considering past periods of net losses (e.g., 2022, 2021).
Inconsistent Revenue and Net Income Growth
Revenue growth has been inconsistent, from $569.545M in 2021 to $703.235M in 2024. Net income has fluctuated significantly, with a substantial net loss in 2022 (-$77.605M) and a lower net income in 2023 ($13.756M) compared to 2024 ($126.712M).
May 2025
16
Ex-Dividend Date
May 2025
30
Next Dividend Date
August 2025
5
Next Earnings Date
H: $0.17
A: $0.17
L: $0.16
H: 188.31M
A: 186.27M
L: 185.20M
Sabra Health Care REIT, Inc. as of March 31, 2025 investment portfolio included 364 real estate properties held for investment (consisting of (i) 224 skilled nursing/transitional care facilities, (ii) 39 senior housing communities (senior housing - leased), (iii) 69 senior housing communities operated by third-party property managers pursuant to property management agreements (senior housing - managed), (iv) 17 behavioral health facilities and (v) 15 specialty hospitals and other facilities), 15 investments in loans receivable (consisting of three mortgage loans and 12 other loans), four preferred equity investments and two investments in unconsolidated joint ventures. As of March 31, 2025, Sabras real estate properties held for investment included 37,075 beds/units, spread across the United States and Canada.
19.75 USD
The 39 analysts offering 1 year price forecasts for SBRA have a max estimate of 21.00 and a min estimate of 18.00.